−3.46USD
−134.70 MUSD
309.20 MUSD
41.10 M
About Cardlytics, Inc. Common Stock
Sector
Industry
CEO
Karim Temsamani
Website
Headquarters
Atlanta
Employees (FY)
434
Founded
2008
ISIN
US14161W1053
FIGI
BBG00225ZDD0
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CDLX is 11.94 USD — it has decreased by 1.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cardlytics, Inc. Common Stock stocks are traded under the ticker CDLX.
Cardlytics, Inc. Common Stock is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
CDLX stock is 4.31% volatile and has beta coefficient of 2.85. Check out the list of the most volatile stocks — is Cardlytics, Inc. Common Stock there?
One year price forecast for Cardlytics, Inc. Common Stock has a max estimate of 18.00 USD and a min estimate of 17.00 USD.
CDLX earnings for the last quarter are −0.63 USD whereas the estimation was −0.65 USD which accounts for 3.08% surprise. Estimated earnings for the next quarter are −0.23 USD. See more details about Cardlytics, Inc. Common Stock earnings.
Cardlytics, Inc. Common Stock revenue for the last quarter amounts to 79.01 M USD despite the estimated figure of 80.05 M USD. In the next quarter revenue is expected to reach 89.55 M USD.
Yes, you can track Cardlytics, Inc. Common Stock financials in yearly and quarterly reports right on TradingView.
CDLX stock has fallen by 11.03% compared to the previous week, the month change is a 10.49% fall, over the last year Cardlytics, Inc. Common Stock has showed a 74.82% increase.
CDLX net income for the last quarter is −100.84 M USD, while the quarter before that showed −23.97 M USD of net income which accounts for −320.75% change. Track more Cardlytics, Inc. Common Stock financial stats to get the full picture.
Today Cardlytics, Inc. Common Stock has the market capitalization of 537.25 M, it has increased by 2.64% over the last week.
No, CDLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CDLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cardlytics, Inc. Common Stock stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 434.00 employees. See our rating of the largest employees — is Cardlytics, Inc. Common Stock on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cardlytics, Inc. Common Stock technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cardlytics, Inc. Common Stock stock shows the neutral signal. See more of Cardlytics, Inc. Common Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cardlytics, Inc. Common Stock future price: according to them, CDLX price has a max estimate of 18.00 USD and a min estimate of 17.00 USD. Read a more detailed Cardlytics, Inc. Common Stock forecast: see what analysts think of Cardlytics, Inc. Common Stock and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cardlytics, Inc. Common Stock EBITDA is −35.13 M USD, and current EBITDA margin is −11.05%. See more stats in Cardlytics, Inc. Common Stock financial statements.